The economic returns of ending the AIDS epidemic as a public health threat - HAL Accéder directement au contenu
Article dans une revue Health Policy Année : 2019

The economic returns of ending the AIDS epidemic as a public health threat

Mead Over
  • Fonction : Auteur
John Stover
  • Fonction : Auteur

Résumé

BACKGROUND: In 2016, countries agreed on a Fast-Track strategy to "end the AIDS epidemic by 2030". The treatment and prevention components of the Fast-Track strategy aim to markedly reduce new HIV infections, AIDS-related deaths and HIV-related discrimination. This study assesses the economic returns of this ambitious strategy. METHODS: We estimated the incremental costs, benefits and economic returns of the Fast-Track scenario in low- and middle-income countries, compared to a counterfactual defined as maintaining coverage of HIV-related services at 2015 levels. The benefits are calculated using the full-income approach, which values both the changes in income and in mortality, and the productivity approach. FINDINGS: The incremental costs of the Fast-Track scenario over the constant scenario for 2017-2030 represent US$86 billion or US$13.69 per capita. The full-income valuation of the incremental benefits of the decrease in mortality amounts to US$88.14 per capita, representing 6.44 times the resources invested for all countries. These returns on investment vary by region, with the largest return in the Asia-Pacific region, followed by Eastern and Southern Africa. Returns using the productivity approach are smaller but ranked similarly across regions. INTERPRETATION: In all regions, the economic and social value of the additional life-years saved by the Fast-Track approach exceeds its incremental costs, implying that this strategy for ending the AIDS epidemic is a sound economic investment.
Loading...

Dates et versions

hal-01994510, version 1 (25-01-2019)

Identifiants

Citer

Erik Lamontagne, Mead Over, John Stover. The economic returns of ending the AIDS epidemic as a public health threat. Health Policy, 2019, 123 (1), pp.104-108. ⟨10.1016/j.healthpol.2018.11.007⟩. ⟨hal-01994510⟩
19 Consultations
0 Téléchargements
Dernière date de mise à jour le 21/04/2024
comment ces indicateurs sont-ils produits

Altmetric

Partager

Gmail Facebook Twitter LinkedIn Plus